Effect of rapamycin and interleukin-2 on regulatory CD4 +CD25+Foxp3+ T cells in mice after allogenic corneal transplantation

Transplantation Proceedings

Volumn 45, Issue 2, 2013, Pages 528-537

  Wang, X ^a   Wang, W ^a   Xu, J ^a   Le, Q ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; MESSENGER RNA; RAPAMYCIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA1;

ALLOGENIC CORNEAL TRANSPLANTATION; ANIMAL EXPERIMENT; AQUEOUS HUMOR; ARTICLE; CD4+ CD25+ T LYMPHOCYTE; CLINICAL PROTOCOL; CONCENTRATION (PARAMETERS); CORNEA TRANSPLANTATION; DONOR; FEMALE; GENE EXPRESSION; GRAFT RECIPIENT; GRAFT SURVIVAL; LYMPH NODE; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PENETRATING KERATOPLASTY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; SPLEEN;

ANIMALS; AQUEOUS HUMOR; BIOLOGICAL MARKERS; CORNEA; CORNEAL TRANSPLANTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; DRUG THERAPY, COMBINATION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GRAFT REJECTION; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE AGENTS; INTERLEUKIN-10; INTERLEUKIN-2; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEOVASCULARIZATION, PHYSIOLOGIC; RNA, MESSENGER; SIROLIMUS; T-LYMPHOCYTES, REGULATORY; TIME FACTORS; TRANSFORMING GROWTH FACTOR BETA1; TRANSPLANTATION TOLERANCE;

EID: 84875228591     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2012.06.064     Document Type: Article

References (40)

1. Y.B. Liang, D.S. Friedman, T.Y. Wong Prevalence and causes of low vision and blindness in a rural Chinese adult population: the Handan Eye Study Ophthalmology 115 2008 1965
2. J.X. Hong, J.J. Xu, M.J. Sheng Pediatric penetrating keratoplasty in Shanghai: a retrospective multiple centre study from 2003 to 2007 Chin Med J (Engl) 121 2008 1911
3. S.V. Patel, N.N. Diehl, D.O. Hodge Donor risk factors for graft failure in a 20-year study of penetrating keratoplasty Arch Ophthalmol 128 2010 418
4. M. Khattar, W. Chen, S.M. Stepkowski Expanding and converting regulatory T cells: a horizon for immunotherapy Arch Immunol Ther Exp (Warsz) 57 2009 199
5. S. Hori, T. Nomura, S. Sakaguchi Control of regulatory T cell development by the transcription factor Foxp3 Science 299 2003 1057
6. P. Hoffmann, J. Ermann, M. Edinger Donor-type CD4(+) CD25(+) regulatory T cells suppress lethal acute graft-versus-host disease after allogeneic bone marrow transplantation J Exp Med 196 2002 389
7. E. Shevach Regulatory T cells in autoimmunity Annu Rev Immunol 18 2000 423
8. S. Sakaguchi, N. Kaguchi, J. Shimizu Immunologic tolerance maintained by CD25 + CD4 + regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance Immunol Rev 182 2001 18
9. G. Korczak-Kowalska, P. Wierzbicki, K. Bocian The influence of immunosuppressive therapy on the development of CD4+CD25+ T cells after renal transplantation Transplant Proc 39 2007 2721
10. P. Thompson, D. Xu, I. Brunette Combined effect of rapamycin and cyclosporine in the prevention of rat corneal allograft rejection Transplant Proc 30 1998 1033
11. M. Battaglia, A. Stabilini, B. Migliavacca Rapamycin promotes expansion of functional CD4+CD25+FOXP3+ regulatory T cells of both healthy subjects and type I diabetic patients J Immunol 177 2006 8338
12. K. Bocian, J. Borysowski, P. Wierzbicki Rapamycin, unlike cyclosporine A, enhances suppressive functions of in vitro-induced CD4+CD25+ Tregs Nephrol Dial Transplant 25 2010 710
13. + regulatory T cells in allotransplantation Transplantation 89 2010 928
14. + T cells in renal recipients Transpl Int 22 2009 884
15. L. Lu, X.F. Qian, J.H. Rao Rapamycin promotes the expansion of CD4+Foxp3+ regulatory T cells after liver transplantation Transplant Proc 42 2010 1755
16. C.C. Baan, B.J. van der Mast, M. Klepper Differential effect of calcineurin inhibitors, anti-CD25 antibodies and rapamycin on the induction of Foxp3 in human T cells Transplantation 80 2005 110
17. J.D. Powell, G.M. Delgoffe The mammalian target of rapamycin: linking T cell differentiation, function, and metabolism Immunity 33 2010 301
18. + T cells in mice Transpl Immunol 17 2007 153
19. M. De la Rosa, S. Rutz, H. Dorninger Interleukin-2 is essential for CD4+CD25+ regulatory T cell function Eur J Immunol 34 2004 2480
20. + regulatory T cells Eur J Immunol 38 2008 1643
21. S. Asanuma, J. Tanaka, J. Sugita Expansion of CD4(+)CD25(+) regulatory T cells from cord blood CD4(+) cells using the common γ-chain cytokines (IL-2 and IL-15) and rapamycin Ann Hematol 90 2011 617
22. J. Plsková, L. Kuffová, V. Holán Evaluation of corneal graft rejection in a mouse model Br J Ophthalmol 86 2002 108
23. C.K. Joo, J.S. Pepose, P.M. Stuart T-cell mediated responses in a murine model of orthotopic corneal transplantation Invest Ophthalmol Vis Sci 36 1995 1530
24. M.K. Jenkins The role of cell division in the induction of clonal anergy Immunol Today 13 1992 69
25. T. Schmelzle, M.N. Hall TOR, a central controller of cell growth Cell 103 2000 253
26. G.M. Delgoffe, T.P. Kole, Y. Zheng The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment Immunity 30 2009 832
27. S. Sauer, L. Bruno, A. Hertweck T cell receptor signaling controls Foxp3 expression via PI3K, Akt, and mTOR Proc Natl Acad Sci USA 105 2008 7797
28. S. Basu, T. Golovina, T. Mikheeva Cutting edge: Foxp3-mediated induction of pim2 allows human T regulatory cells to preferentially expand in rapamycin J Immunol 180 2008 5794
29. H.R. Turnquist, G. Raimondi, A.F. Zahorchak Rapamycin-conditioned dendritic cells are poor stimulators of allogeneic CD4+ T cells, but enrich for antigen-specific foxp3+ T regulatory cells and promote organ transplant tolerance J Immunol 178 2007 7018
30. J.M. Palmer, B.J. Chen, D. De Oliveira Novel mechanism of rapamycin in GVHD: increase in interstitial regulatory T cells Bone Marrow Transplant 45 2010 379
31. L. Tan, W.M. Howell, J.L. Smith Sequential monitoring of peripheral T-lymphocyte cytokine gene expression in the early post renal allograft period Transplantation 71 2001 751
32. G. Alì, L. Boldrini, M. Lucchi Treatment with interleukin-2 in malignant pleural mesothelioma: immunological and angiogenetic assessment and prognostic impact Br J Cancer 101 2009 1869
33. M.I. Roh, H.S. Kim, J.H. Song Concentration of cytokines in the aqueous humor of patients with naive, recurrent and regressed CNV associated with and after bevacizumab treatment Retina 29 2009 523
34. + regulatory T cells and for expansion of these cells J Immunol 178 2007 2018
35. M.A. Burchill, J. Yang, C. Vogtenhuber IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells J Immunol 178 2007 280
36. + regulatory T cells J Immunol 172 2004 5287
37. D.R. Littman, A.Y. Rudensky Th17 and regulatory T cells in mediating and restraining inflammation Cell 140 2010 845
38. A. Amirzargar, M. Lessanpezeshki, A. Fathi TH1/TH2 cytokine analysis in Iranian renal transplant recipients Transplant Proc 37 2005 2985
39. J. Alberu, Y. Richaud-Patin, L.G. Vazquez-Lavista In vivo IL-10 and TGF-beta production by PBMC from long-term kidney transplant recipients with excellent graft function: a possible feedback mechanism participating in immunological stability Clin Transplant 18 2004 174
40. M. Mohammadnia, G. Solgi, M. Ranjbar Serum levels of interleukin (IL)-10, IL-17, transforming growth factor (TGF)-β1, and interferon-γ cytokines and expression levels of IL-10 and TGF-β1 genes in renal allograft recipients after donor bone marrow cell infusion Transplant Proc 43 2011 495